您要查找的是不是：
- There is a acellular pertussis vaccine. 無(wú)細胞百日咳疫苗。
- tetanus, diphtheria & pertussis vaccine 破傷風(fēng)、白喉和百日咳疫苗<生物制品>
- TPer/Vac(tetanus and pertussis vaccine) 破傷風(fēng)和百日咳疫苗[生物制劑]
- Diphtheria Tetanus Pertussis and Poliomyeli-tis Vaccine 白喉-破傷風(fēng)-百日咳-脊髓灰質(zhì)炎菌苗[生物制劑]
- Pertussis vaccines -- are they safe and effective? 百日咳菌苗-它們是安全與有效的?
- diphtheria and tetanus toxoids and pertussis vaccine 白喉、破傷風(fēng)類(lèi)毒素、百日咳菌苗混合制劑, 百白破三聯(lián)制劑
- adsorbed diphtheria and tetanus toxoids and pertussis vaccine 吸附白喉、破傷風(fēng)類(lèi)毒素, 百日咳菌苗混合制劑, 吸附百白破三聯(lián)制劑
- adsorbed diphtheria, tetanus toxoid and pertussis vaccine 吸附白喉; 破傷風(fēng)類(lèi)毒素和百日咳菌苗混合制劑
- diphtheria and tetanus toxoids and pertussis vaccine, adsorbed 吸附白喉百日咳破傷風(fēng)三聯(lián)菌苗, 吸附白百破三聯(lián)菌苗
- The infant receives three injections of pertussis vaccine at one-month intervals. 嬰兒以一個(gè)月為間隔，接受三次百日咳疫苗的注射。
- Conclusion The developed quality control method was suitable for the acellular pertussis vaccine in China. 結論所建立的質(zhì)量控制方法可用于我國無(wú)細胞百日咳疫苗的質(zhì)量控制。
- Most infants receive a pertussis vaccine, but its effectiveness subsides after about 10 years. 大多數嬰兒會(huì )接受百日咳疫苗的接種，但是在十年后效果會(huì )降低。
- The acellular pertussis vaccine manufactured by Lanzhou Institute of Biological Products was investigated for purity、toxicity and potency. 本文對無(wú)細胞百日咳菌苗的純度、免疫力和毒性進(jìn)行了研究。
- Acellular pertussis vaccine recommended by WHO should contain five components: PT, FHA, PRN, FIM2 and FIM3, the major component is PT. FIM2和FIM3是百日咳桿菌的3種保護性抗原，在百日咳桿菌的致病和免疫過(guò)程中起重要作用。
- Objective In order to select the best preparation procedure of the national reference on toxicity of acellular pertussis vaccine. 目的篩選無(wú)細胞百日咳疫苗毒性國家參考品的最佳生產(chǎn)工藝。
- Objective To develop the methods for determination of component content and purity of acellular pertussis vaccine in China. 摘要目的建立我國無(wú)細胞百日咳疫苗組分含量和純度的檢測方法。
- Methods A mouse s point Houhai, point Zhongwan or abdominal cavity was injected with pertussis vaccine and its immune response was observed. 方法對小白鼠后海穴、中脘穴、腹腔注射百日咳疫苗觀(guān)察其免疫力。
- Bordetella pertussis toxin S1 mutant was successfully expressed and purified,which laid a molecular immunological foundation of developing candidate antigen of pertussis vaccine. 成功表達并純化了百日咳毒素S1亞單位突變體,為研制百日咳疫苗候補抗原的相關(guān)分子免疫學(xué)研究奠定了基礎。
- absorbed diphtheria, tetanus and pertussis vaccines 吸附百日咳菌苗; 白喉和破傷風(fēng)類(lèi)毒素混合制劑
- alum precipitated pertussis vaccine [醫] 明礬沉淀百日咳菌苗
